Clinical trial
A Post Marketing Surveillance (PMS) Study for VPRIV (Velaglucerase Alfa) in India
NCT04429984 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post Marketing Surveillance (PMS) Study for VPRIV (Velaglucerase Alfa) in India
- Lead sponsor
- Shire
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 28, 2021
- Completion date
- April 22, 2023
- Enrollment
- 21 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.